MDB Capital Holdings, LLC Class A (MDBH)

MDB Capital Holdings LLC (MDBH) stock has experienced volatility and a decline over the past six months. The share price declined by 53.33% from March 31, 2025, to March 27, 2026, and lost approximately 15% since November 30, 2025, due to weak Q3 2025 earnings. MDBH reported a Q3 2025 EPS of -$0.46 and revenue of $1.42 million, with a quarterly loss of -$4.7 million, and hit a 52-week low of $2.75 on March 21, 2026. There were stock price increases of over 10% on October 15, 2025, and October 24, 2025. Insider buying activity occurred from December 2024 to June 2025. MDB Capital Holdings reported a net loss of $1.76 million in Q4 2025, despite a 314.0% surge in revenue to $4.73 million. Director Terry Jeb Barton Sr. was awarded 100,000 employee stock options on February 1, 2026, and the company announced transitions in its Board of Directors on February 2, 2026. PatentVest announced a strategic intellectual property collaboration with Porosome Therapeutics on March 11, 2026, highlighted a new legal article on AI patenting strategy on March 30, 2026, and announced a partnership with Life Seal Vascular.

Based on the available information, there is no explicit mention or analysis of demand seasonality for MDB Capital Holdings LLC's products and services. The nature of investment banking and technology development may not inherently exhibit strong seasonality compared to other industries.

MDB Capital Holdings LLC (MDBH) is a U.S.-based financial services holding company operating in investment banking, capital markets, and as a broker-dealer. It advises and underwrites early-stage and micro-cap public companies, focusing on IPOs and capital-raising transactions. The company operates through a broker-dealer & intellectual property service segment and a technology development segment. Its services include underwriting, private placements, M&A advisory, aftermarket trading support, patent research and IP strategy via its PatentVest subsidiary, technology development, and the MDB Direct Trading Platform. MDBH's clients are in technology, healthcare, energy, and industrials.

MDB Capital Holdings LLC is headquartered in the United States, with its principal operations concentrated in California and Texas. Its capital markets activities may involve international investors participating in U.S. offerings, extending its market influence internationally.

MDB Capital Holdings has a history of launching successful IPOs, with all IPOs having traded at twice the IPO price post-launch. The company emphasizes its public venture capital platform and its ability to launch disruptive technology companies. PatentVest publishes Pulse Reports showcasing its expertise. However, the company's stock performance has been disappointing, impacting investor confidence. The difficult microcap market environment has impacted funding opportunities, and a concentrated investor base limits market reach. There have been execution and operational challenges in portfolio companies, and the company has faced a lack of consistent profitability.

Approximately 1.75% of MDB Capital's stock is owned by institutional investors, with 5 institutional owners holding 177,901 shares. Insiders own approximately 7.95% of the company's stock, with Christopher A. Marlett being the largest individual shareholder. Retail investors hold the largest portion, approximately 90.30% of the company's shares.